Conray 43 (Liebel-Flarsheim Company LLC)


Welcome to the PulseAid listing for the Conray 43 drug offered from Liebel-Flarsheim Company LLC. This Radiographic Contrast Agent [EPC],X-Ray Contrast Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Liebel-Flarsheim Company LLC
NON-PROPRIETARY NAME: iothalamate meglumine
SUBSTANCE NAME: IOTHALAMATE MEGLUMINE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Radiographic Contrast Agent [EPC],X-Ray Contrast Activity [MoA]
ROUTE: INTRAVASCULAR
DOSAGE FORM: INJECTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2010-10-11
END MARKETING DATE: 0000-00-00


Conray 43 HUMAN PRESCRIPTION DRUG Details:

Item DescriptionConray 43 from Liebel-Flarsheim Company LLC
LABELER NAME: Liebel-Flarsheim Company LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 430(mg/mL)
START MARKETING DATE: 2010-10-11
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0019-3183_c03aaec4-d659-4805-ae8d-0b582bd72505
PRODUCT NDC: 0019-3183
APPLICATION NUMBER: NDA013295

Other IOTHALAMATE MEGLUMINE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Liebel-Flarsheim Company LLCCysto-Conray II